CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

By afschroeder • December 23, 2025

Patil T, Lin JJ, Cheema PK, Carrizosa DR, Burkard ME, Elamin YY, Desai J, Patel JD, Nagasaka M, Reckamp KL, Waqar SN, Bauman JR, Schram AM, Gadgeel SM, Ma PC, Konduri K, Nguyen D, Misleh J, Bleeker J, Weiss M, Thavaneswaran S, Haura EB, Deegan M, Kaufman J, Srivastava J, Jansen VM, Liu SV. CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions. JCO Precis Oncol. 2025 Aug;9:e2500221. doi: 10.1200/PO-25-00221. Epub 2025 Dec 22. PMID: 41428976.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program

Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, Blangero J, Bowden DW, Carson AP, Chen YI, Chung MK, Curran JE, Darbar[...]

Defining Diagnostic Excellence and Missed Diagnostic Opportunity for the Emergency Department Setting

Berdahl CT, Schiff GD, Venkatesh AK, Seferian EG, Torbati SS, Ptacek MP, Carrascoza-Bolanos J, Qureshi N, Nuckols TK; Multidisciplinary ED Diagnostic Excellence Panel. Defining Diagnostic[...]

The Family Perspectives Project: development and preliminary feasibility of a chaplain-delivered emotional support intervention for families of critically ill patients

Modes ME, Kross EK, Duru OK, Sherman A, Ahluwalia SC, Walling AM, Lazor P, Nuckols TK. The Family Perspectives Project: development and preliminary feasibility of[...]